NCT02518932View on ClinicalTrials.gov

The Effect of VTC-G15 (a Pentapeptide Cleavage Product og GLP-1) on Whole Body Glucose Metabolism in Man

PHASE1UnknownINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2016

Conditions
Insulin Resistance
Interventions
DRUG

Last 5 amino acids of GLP-1

To examine insulinomimetic properties of LVKGR

DRUG

placebo saline

Trial Locations (1)

78209

RECRUITING

ICON PLC, San Antonio

Sponsors

Collaborators (1)

ICON plc
All Listed Sponsors
collaborator

ICON plc

INDUSTRY

collaborator

Massachusetts General Hospital

OTHER

collaborator

National Institute on Aging (NIA)

NIH

lead

Elahi, Dariush, PhD

INDIV